Quick Answer
INTEGRA LIFESCIENCES HOLDINGS CORP reported Operating Income Loss of -$493.37 million for the year ending 2025.
- INTEGRA LIFESCIENCES HOLDINGS CORP showed a decrease of -1,836.5% in Operating Income Loss from 2024 to 2025.
- This data is from INTEGRA LIFESCIENCES HOLDINGS CORP's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), INTEGRA LIFESCIENCES HOLDINGS CORP's Operating Income Loss has declined by 1,140.6%.
- Historical annual values: Fiscal year 2025: -$493.37 million | Fiscal year 2024: $28.41 million | Fiscal year 2023: $111.53 million | Fiscal year 2022: $238.92 million | Fiscal year 2021: $197.23 million | Fiscal year 2020: $151.37 million | Fiscal year 2019: $93.76 million | Fiscal year 2018: $111.00 million | Fiscal year 2017: $44.80 million | Fiscal year 2016: $115.34 million | Fiscal year 2015: $79.59 million | Fiscal year 2014: $67.86 million | Fiscal year 2013: $35.37 million | Fiscal year 2012: $73.78 million | Fiscal year 2011: $54.91 million | Fiscal year 2010: $98.69 million | Fiscal year 2009: $97.82 million | Fiscal year 2008: $47.41 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: